The Punjab Chemists Association (PCA) has announced an immediate statewide halt on the sale of all habit-forming medications, including Pregabalin. The decision is expected to cause significant hardship for patients across the state, particularly those suffering from psychiatric and neurological conditions who rely on valid medical prescriptions for these essential medications. The association has communicated the decision to all unit presidents, secretaries, and members across its regional network, instructing them to ensure strict compliance and notify retail chemists in their respective areas immediately. Additionally, the PCA has advised chemists to dispose of their existing inventory in accordance with legal requirements and established return procedures. Explaining the rationale behind the boycott, PCA Vice President Sudarshan Chaudhary stated in an interaction with the Tribune Group that licensed chemists are subjected to lengthy documentation and record-keeping procedures for psychotropic substances, yet continue to face public and official stigmatization as drug traffickers. He highlighted that Pregabalin, a drug commonly prescribed for specific medical conditions, had recently come under controversy in connection with the Jhota murder case. The sudden decision to suspend the retail sale of Pregabalin and other habit-forming drugs could trigger an acute shortage for patients undergoing regular treatment. Addressing concerns regarding patient distress, Chaudhary suggested that the state government step in to make these medications accessible through government-run medical stores and dispensaries. The PCA stated that the decision was taken in light of the prevailing situation to underscore their commitment to responsible pharmacy practices and the broader campaign against drug abuse. The association’s directive further advises local leadership to report any operational difficulties or requests for clarification back to the central organization.